Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

 

 

COMPANY:

 

 

 

VITAE PHARMACEUTICALS, INC.

 

 

 

 

 

By:

/s/ Jeffrey Hatfield

 

 

Name:

Jeffrey Hatfield

 

 

Title:

Chief Executive Officer

 

SIGNATURE PAGE TO VITAE PHARMACEUTICALS, INC.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT